Perbedaan UBC Medical Indonesia Tbk. dan Venteny Fortuna International Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,48 jt), sedangkan Venteny Fortuna International Tbk. diperdagangkan di Rp61 (kapitalisasi pasar 394,71 M, volume 24 jam 64 jt). Perbedaan utamanya: UBC Medical Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar, dan Venteny Fortuna International Tbk. lebih aktif diperdagangkan (64 jt vs 3,48 jt). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | VTNY | |
|---|---|---|
Kapitalisasi Pasar | 576,7 M | 394,71 M |
Volume | 3,48 jt | 64 jt |
Lot | 34,82 rb | 639,98 rb |
Perputaran | 522,79 jt | 4,15 M |
Harga Rata-rata | 150,13 | 64,9 |
Nilai Transaksi | 522,79 jt | 4,15 M |
Harga Ekuilibrium Indikatif | 148 | 61 |
Volume Ekuilibrium Indikatif | 350 | 1,95 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →PT Venteny Fortuna International Tbk (the Entity) was established based on Notarial Deed No. 7,dated January 29, 2021 of Anastasia Chandra, S.H., M.Kn., Notary in Tangerang. The Entity started its commercial operations in 2021. PT Venteny Fortuna International Tbk is the parent entity, whereas Junichiro Waide is the ultimate beneficial owner.
Selengkapnya di halaman VTNY →